US11111508B2ActiveUtilityPatentIndex 54
Modified CAS9 compositions and methods of use
Est. expiryOct 30, 2035(~9.3 yrs left)· nominal 20-yr term from priority
Inventors:LAU NELSON
C12N 9/22C12N 15/11C07K 2319/00C12N 15/907C12N 2310/20C12N 9/222
54
PatentIndex Score
1
Cited by
10
References
7
Claims
Abstract
The invention features Cas9 fusion polypeptides. In one embodiment of the invention, Cas9 is fused to a SNAP tag that enhances Cas9's gene repair function.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A Cas9 fusion polypeptide having the sequence of SEQ ID NO:2.
2. A polynucleotide encoding the polypeptide of claim 1 .
3. An expression vector comprising the polynucleotide of claim 2 .
4. A cell comprising the expression vector of claim 3 .
5. A method for enhancing transgene integration efficiency, the method comprising expressing in a cell a vector encoding the polypeptide of claim 1 , a small guide RNA, and a transgene suitable for integration into a genome.
6. The method of claim 5 , wherein the integration efficiency is increased at least about 2-fold relative to the level present in a corresponding control cell expressing wild-type Cas9.
7. A method for enhancing Homologous DNA Recombination (HDR), the method comprising expressing in a cell vector encoding the polypeptide of claim 1 , a small guide RNA, and a transgene suitable for integration into a genome.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.